Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Revenue (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Revenue for 16 consecutive years, with $64.5 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 15.68% to $64.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $249.6 million through Dec 2025, up 13.53% year-over-year, with the annual reading at $249.6 million for FY2025, 13.53% up from the prior year.
  • Revenue for Q4 2025 was $64.5 million at Lemaitre Vascular, up from $61.0 million in the prior quarter.
  • The five-year high for Revenue was $64.5 million in Q4 2025, with the low at $35.9 million in Q1 2021.
  • Average Revenue over 5 years is $49.0 million, with a median of $48.1 million recorded in 2023.
  • The sharpest move saw Revenue soared 63.66% in 2021, then increased 1.72% in 2022.
  • Over 5 years, Revenue stood at $39.5 million in 2021, then increased by 3.67% to $41.0 million in 2022, then increased by 19.36% to $48.9 million in 2023, then grew by 13.98% to $55.7 million in 2024, then increased by 15.68% to $64.5 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $64.5 million, $61.0 million, and $64.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.